Viral sequence analysis of occult HBV infection and its reactivation in immunosuppressed patients

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 3, 2012, Pages 457-465

  Ferraro, Donatella ^a   Pizzillo, P ^a   Urone, N ^a   Iannitto, E ^a   Craxi A ^a   Di Stefano, R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

HBV reactivation; Molecular epidemiology; Occult HBV; Phylogenetic analysis

Indexed keywords

AMINO ACID; CORTICOSTEROID; CYTOTOXIC AGENT; LAMIVUDINE; NUCLEOTIDE;

ADULT; AGED; ARTICLE; CHEMOTHERAPY; CLINICAL ARTICLE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; OCCULT BLOOD; PHYLOGENY; SEQUENCE ANALYSIS; VIRUS MUTATION; VIRUS REACTIVATION;

DNA, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

HEPATITIS B VIRUS;

EID: 84868133842     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Raimondo G, Allain JP, Brunetto MR et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49:652-7.
2. Brechot C, Thiers Y, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely ́occult́?. Hepatology 2001; 34:194-203. (Pubitemid 32591500)
3. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol 2005; 34:S15-S21. (Pubitemid 43197745)
4. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002; 9:243-57.
5. Iannitto E, Minardi V, Calvaruso G, et al.Hepatitis B reactivation and alemtuzumab therapy. Eur J Haematol 2005; 74:254-8.
6. Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, Levrero M. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 2006; 130:823-37. (Pubitemid 43374531)
7. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J Hepatol 2009; 51:581-92.
8. Nguyen T, Desmond P, Locarnini S. The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B. Hepatol Int 2009; 3:S5-S15.
9. Hollinger F.B. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 2007; 14:S11-S15.
10. Osiowy C. Detection of HBsAg Mutants. J Med Virol 2006; 78: S48-S51. (Pubitemid 43993465)
11. Kreuts C. Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cell Mol Med 2002; 6:113-43.
12. Katsoulidou A, Paraskevis D, Magiorkinis E, et al. Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol 2009; 81:815-25.
13. Weber B. Genetic variability of the S gene of hepatitis B virus. Clinical and diagnostic impact. J Clin Virol 2005; 32:102-12. (Pubitemid 40093960)
14. Khan N, Guarnieri M, Ahn SH, et al. Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J Virol 2004; 78:3262-70. (Pubitemid 38568266)
15. Warner N, Locarnini S. The antiviral drug selected hepatitis B virus rtA181T/sW172*mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 2008; 48:88-98. (Pubitemid 351975534)
16. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, Levrero M, Raimondo G. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007; 45:277-85. (Pubitemid 46374584)
17. Hass M, Hannoun C, Kalinina T, Sommer G, Manegold C, Gunther S. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 2005; 42:93-103. (Pubitemid 40911316)
18. Ferraro D, Pizzillo P, Di Marco V, Vultaggio A, Iannitto E, Venezia G, Craxí A, Di Stefano R. Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable? Liver Int 2009; 29:1171-77.
19. Kumar, S, Tamura K, Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004; 5:150-63.
20. Wallace LA, Echevarria JE, Echevarria JM, Carman WF. Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J Infect Dis 1994; 170:1300-303. (Pubitemid 24328642)
21. Chong-Jin O, Wei Ning C, Shiuan K, Gek Keow L. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants. J Infect Dis 1999; 1:259-63. (Pubitemid 29028367)
22. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 1997; 3:786-91.
23. Chouteau P, Le Seyec J, Cannie I, Nassal M, GuguenGuillouzo C, Gripon P. A short N-proximal region in the large envelope protein harbours a determinant that contributes to the species specificity of human B hepatitis. J Virol 2001; 75:11565-11572. (Pubitemid 33063248)
24. Seeger C, Zoulim F, Mason WS. Hepadnaviruses. In: Knipe DH, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, et al, editors. Fields Virology 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2007.
25. Jenna S, Sureau C Role of the Antigenic Loop of the Hepatitis B Virus Envelope Proteins in Infectivity of Hepatitis Delta Virus. J Virol 2005; 79:10460-66. (Pubitemid 41098586)
26. Candotti D, Grabarczyk P, Ghiazza P, et al. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008; 49:537-47.
27. Schaefer S. Hepatitis B virus. Significance of genotypes. J Viral Hepat 2005; 12:111-24.
28. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease N Engl J Med 1999; 341:22-26. (Pubitemid 29293716)
29. Pollicino T, Squadrito G, Cerenzia G, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004; 126:102-10. (Pubitemid 38040728)